Target
Prostate Specific Membrane Antigen (PSMA)
8 abstracts
Abstract
PRadR: PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer, a multicentric phase I/II.Org: Institut de Recherche en Cancérologie de Montpellier, Inserm U1296, Department of Nuclear Medicine, Grenoble Alpes University Hospital, Nuclear Medicine Department, Centre Jean Perrin, UNIV Lyon-Université Claude Bernard Lyon 1,
Abstract
Xerostomia and ocular dryness as predictors of PSA response to Lu177-PSMA-617 in metastatic castration resistant prostate cancer.Org: Indiana University Simon Comprehensive Cancer Center,
Abstract
The real-world impact of next-generation sequencing in advanced stages of solid tumor malignancies.Org: Orlando Health Cancer Institute, University of South Florida Morsani College of Medicine, Comprehensive Hematology-Oncology,
Abstract
Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging.Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Hospital Universitario 12 de Octubre, Madrid, Spain, Spain, University of California San Francisco,
Abstract
A smart clinical cohort selection system for clinical oncology research.Org: FAST National University of Computer and Emerging Sciences, CureMD Inc,
Abstract
Incorporation of fellow-driven, interactive case-based discussions to improve fellowship education in a new fellowship program.Org: The University of Texas Health Science Center at Houston (UTHealth Houston) McGovern Medical School, University of Texas at Houston, University of Texas Health Sciences Center at Houston, University of Texas at Houston Health Science Center,
Abstract
Retrospective review of 250 gallium-68 PSMA scans in prostate cancer patients in Health Canada Special Access Program.Org: Lions Gate Hospital, INITIO MEDICAL,
Abstract
Incidence of solid malignancies (SM) among patients with Waldenström macroglobulinemia (WM): Analysis of the SEER database (2000-2019).Org: Roswell Park Comprehensive Cancer Center, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, Winship Cancer Institute of Emory University, Atlanta, GA, Emory University, Atlanta, GA, Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, Department of Medicine, Massachusetts General Hospital, Boston, MA, Department of Medicine, Emory University School of Medicine, Atlanta, GA, Department of Urology, Emory University School of Medicine, Atlanta, GA, Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Instititute, Saint Vincent Hospital Cancer Center Green Bay,